Zoetis
Manufacturing · New Jersey, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
10 Sylvan Way, Parsippany, New Jersey, 0...Phone Number
(973) 822-7000Website
www.zoetis.comRevenue
$9.5 BillionStock Symbol
ZTSIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
17
1
3
3
2
2
About Zoetis
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.Explore more
Zoetis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zoetis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Zoetis has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Zoetis
Funding: Get notified immidiatlly once Zoetis has new funding data
Zoetis, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Zoetis is spiking on competitors!
Click to see if Zoetis had a recent Job posting/layoffs
Earning: See what the market has to say on Zoetis recently announced quarterly report
Product Launch: Get notified when Zoetis launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Zoetis
Find 3 more new buyers
Compare Similar Companies to Zoetis
Compare insights from companies similar to Zoetis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Zoetis
$9.5B
10K+
Public
$2.3B
1952
RV
Renato Vilas BoasRegional Chief Financial Officer, Latin America (Canada)
$65.8B
10K+
Public
$20.9B
1891
AM
Allyson MunsellChief of Staff To the Senior Vice President, Global Communications
Company Profile Activity
Activity Insights
Zoetis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zoetis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zoetis.
Zoetis financials insights
Gather financial insights about Zoetis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$2.2B
2023
Grant
$15.3M
Zoetis Tech Stack
A closer look at the technologies used by Zoetis
Most Recent Scoops
Person-Based
Earnings, Events, Finance
Person-Based
Earnings, Finance
Open Position
Open Position
Open Position
Zoetis News & Media
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zoetis Inc. (ZTS)
Zoetis Shareholders Between January 14, 2025 and May 6, 2026 - Contact Bernstein Liebhard For More Information Regarding LawsuitZOETIS DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important July 27 Deadline in Securities Class Action – ZTS
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”), of the important July 27, 2026 lead plaintiff deadline.ZOETIS INC. INVESTORS WITH LOSSES HAVE UNTIL JULY 27, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
Zoetis Shareholders Between January 14, 2025 and May 6, 2026 - Contact Bernstein Liebhard For More Information Regarding LawsuitZoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BENSALEM, Pa., July 21, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Zoetis Inc. ("Zoetis" or the "Company") (NYSE:ZTS). IF YOU ARE AN INVESTOR WHO...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zoetis
Sign Up For FreeTo access detailed company insights
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The comp... Read More
